Source: NASDAQ US Markets / 22 Feb 2024 02:52:27 America/Chicago
(RTTNews) - Hikma Pharmaceuticals plc (HIK.L, HKMPY, HKMPF) reported that its profit attributable to shareholders for the year ended 31 December 2023 increased to $190 million or 85 cents per share from $188 million or 84 cents per share in the prior year.
https://www.nasdaq.com/articles/hikma-pharma-fy-profit-increases